News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 145–180
- Matches
- 662
- Sources here
- 23
- Companies here
- 14
Search results
Stored financial headlines
Active search
662 matching headlines
Ticker or company: RAVEMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Travere Therapeutics Reports Second Quarter 2026 Financial Results
Travere Therapeutics (Nasdaq: TVTX) reported strong second-quarter 2026 financial results, driven by robust demand for FILSPARI, with U.S. net product sales growing 96% year-over-year to $141 million. The company announced the successful launch of FILSPARI in FSGS and continued growth in IgA nephropathy, alongside …
TVTX
main company
Sharemaestro market context
Trend signal active
52 weeks +246.8% · Next-week setup positive 56.5%
Travel & Leisure Co. SEC Filing (Aug 5, 2026)
This article reports on a Form 144 SEC filing by Travel & Leisure Co. (TNL) on August 5, 2026. The filing indicates a proposed sale of 4,150 shares of common stock, acquired via stock option exercise, with an aggregate market value of $328,833.50. The …
TNL
main company
Sharemaestro market context
Trend signal active
52 weeks +24.9% · Next-week setup positive 55.6%
Allegiant Airlines announces new in-flight perks
Allegiant Airlines has introduced new in-flight perks, including complimentary beverage service for all passengers and additional benefits for Allways Rewards Visa cardholders. The airline also plans to launch a premium seating class, "Allegiant First," on select aircraft starting in 2027, offering enhanced comfort and …
ALGT
main company
Sharemaestro market context
Trend signal active
52 weeks +41.5%
Global Business Travel Group Inc (GBTG) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Global Business Travel Group Inc (GBTG), highlighting its current earnings forecast score, average price target, and analyst ratings. It also includes frequently asked questions about the company's expected revenue, price target, and recent EPS performance. The consensus …
GBTG
main company
Sharemaestro market context
Trend signal active
52 weeks +14.5% · Next-week setup negative 44.4%
Travelers (TRV) Completes Nationwide Synergy Rollout For Life Sciences Liability Coverage
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Travelers Companies has completed the nationwide rollout of its Synergy product liability insurance for life sciences companies with its launch in California. The Synergy …
Sharemaestro market context Trend signal active 52 weeks +128.4% · Next-week setup negative 24.0%Shareholders Approve Merger, Global Business Travel Sold
Global Business Travel Group's stockholders overwhelmingly approved a merger agreement with Gaia Purchaser, Inc., leading to Global Business Travel Group becoming a wholly owned subsidiary. Approximately 94.95% of eligible Class A common shares were represented at the virtual special meeting, demonstrating strong shareholder engagement. …
GBTG
main company
Sharemaestro market context
Trend signal active
52 weeks +14.5% · Next-week setup negative 44.4%
Global Business Travel Group (NYSE: GBTG) CFO sells 20K shares at $9.43
Global Business Travel Group's CFO, Karen A. Williams, sold 20,000 shares of Class A Common Stock on August 5, 2026, at a weighted average price of $9.43 per share, totaling approximately $189,000. Following this transaction, Williams directly holds 548,257 shares. The sale was an …
GBTG
main company
Sharemaestro market context
Trend signal active
52 weeks +14.5% · Next-week setup negative 44.4%
Travelers (TRV) Stock Looks About Right As Earnings Support Holds
Travelers Companies (TRV) stock appears fairly valued based on its current P/E ratio of 9.5x, which is close to its estimated fair P/E of 9.7x and in line with peers. Despite a strong 169.5% return over the past five years, the market price suggests …
TRV
main company
Sharemaestro market context
Trend signal active
52 weeks +36.2% · Next-week setup positive 63.0%
Does Allegiant’s Profit Rebound and Premium Pivot Reshape The Bull Case For Allegiant Travel (ALGT)?
Allegiant Travel Company recently reported improved financial results for Q2 2026 and the first half of 2026, with revenue rising and net loss narrowing, and then moving to net income. This occurred alongside a new pilot contract with significant pay increases and bonuses, and …
ALGT
main company
Sharemaestro market context
Trend signal active
52 weeks +41.5%
Travel + Leisure Co. (NYSE:TNL) Announces $0.60 Quarterly Dividend
Travel + Leisure Co. (NYSE:TNL) has declared a quarterly dividend of $0.60 per share, payable on September 30th to shareholders of record as of September 16th. This dividend represents an annualized yield of 3.1% and a payout ratio of 33.5%, which analysts expect to …
TNL
main company
Sharemaestro market context
Trend signal active
52 weeks +24.9% · Next-week setup positive 55.6%
Travere Therapeutics, Inc. Stock 12‑Month Price Target Raised to $65.71, Implies 17% Upside
Analysts have raised the average 12-month price target for Travere Therapeutics, Inc. (TVTX) stock to $68.36, up from $59.14. This new target suggests a potential upside of approximately 22% from the August 4th closing price. The consensus rating from 15 analysts remains a "Buy," …
TVTX
main company
Sharemaestro market context
Trend signal active
52 weeks +246.8% · Next-week setup positive 56.5%
Travere Therapeutics Inc (TVTX) (Q2 2026) Earnings Call Highlights: Record FILSPARI Demand and ...
Travere Therapeutics reported strong Q2 2026 results, driven by record demand for FILSPARI, particularly with its successful launch in FSGS, exceeding initial expectations. The company also strengthened its balance sheet and expanded its rare kidney disease portfolio through a new licensing agreement, despite facing …
TVTX
main company
Sharemaestro market context
Trend signal active
52 weeks +246.8% · Next-week setup positive 56.5%
Travelzoo bets on membership growth despite swing to loss
Travelzoo reported record membership renewals in Q2 2026, driven by significant investment in its paid Club programme, despite a 3% revenue drop to $23.3m and a swing to a $2.8m operating loss. The company's strategy focuses on a recurring revenue model, anticipating Club membership …
TZOO
main company
Sharemaestro market context
Trend signal ended
52 weeks -29.4%
UBS Adjusts Price Target on Allegiant Travel to $111 From $103, Maintains Neutral Rating
UBS has increased its price target for Allegiant Travel Company (NASDAQ: ALGT) to $111 from $103, while maintaining a Neutral rating on the stock. This adjustment follows Allegiant Travel's Q2 2026 earnings call and report, which indicated a Q2 revenue of $943.5M and an …
ALGT
main company
Sharemaestro market context
Trend signal active
52 weeks +41.5%
TRAVERE THERAPEUTICS, INC. : JEFFERIES RAISES TARGET PRICE TO $64 FROM $54
Jefferies has raised its target price for Travere Therapeutics, Inc. (TVTX.O) to $64 from the previous $54. This indicates a more optimistic outlook by the firm on the pharmaceutical company's future performance. The report was published by Reuters on August 5, 2026.
TVTX
main company
Sharemaestro market context
Trend signal active
52 weeks +246.8% · Next-week setup positive 56.5%
Allegiant Travel Co (ALGT) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic Integration Drive Strong Performance
Allegiant Travel Co (ALGT) reported record standalone revenue and an industry-leading operating margin for Q2 2026, with the Sun Country integration progressing well. The company posted a combined revenue of $943.5 million and a consolidated EPS of $2.19, leading to a full-year EPS outlook …
ALGT
main company
Sharemaestro market context
Trend signal active
52 weeks +41.5%
Earnings call transcript: Travere Therapeutics jumps on q2 2026 sales beat
Travere Therapeutics reported Q2 2026 revenue of $169.6 million, exceeding analyst forecasts, driven by strong sales of its kidney drug FILSPARI. The drug's sales rose 96% year-over-year to $141.1 million, benefiting from accelerated demand in both IgA nephropathy and the newly launched FSGS indication. …
TVTX
main company
Sharemaestro market context
Trend signal active
52 weeks +246.8% · Next-week setup positive 56.5%
Press Release: Travel + Leisure Co. Declares Cash Dividend
Travel + Leisure Co. announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share on the company's common stock. The dividend is payable on September 13, 2024, to shareholders of record as of August 29, 2024.
TNL
main company
Sharemaestro market context
Trend signal active
52 weeks +24.9% · Next-week setup positive 55.6%
American Express Global Business Travel posts Q2 2026 revenue $870M, adjusted EBITDA $178M
American Express Global Business Travel (GBTG) reported strong Q2 2026 results, with revenue up 38% year-over-year to $870 million and adjusted EBITDA reaching $178 million. The company highlighted significant business momentum, including $3.5 billion in new wins, a 95% customer retention rate, and advancements …
GBTG
main company
Sharemaestro market context
Trend signal active
52 weeks +14.5% · Next-week setup negative 44.4%